EP1883420A4 - Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease - Google Patents

Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease

Info

Publication number
EP1883420A4
EP1883420A4 EP06750581A EP06750581A EP1883420A4 EP 1883420 A4 EP1883420 A4 EP 1883420A4 EP 06750581 A EP06750581 A EP 06750581A EP 06750581 A EP06750581 A EP 06750581A EP 1883420 A4 EP1883420 A4 EP 1883420A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
compositions
methods
autoimmune disease
therapeutic response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06750581A
Other languages
German (de)
French (fr)
Other versions
EP1883420A2 (en
Inventor
Thomas E Carey
Thankam S Nair
Jennifer Gray Beckham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of EP1883420A2 publication Critical patent/EP1883420A2/en
Publication of EP1883420A4 publication Critical patent/EP1883420A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
EP06750581A 2005-04-18 2006-04-18 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease Withdrawn EP1883420A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67245305P 2005-04-18 2005-04-18
PCT/US2006/014575 WO2006113723A2 (en) 2005-04-18 2006-04-18 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease

Publications (2)

Publication Number Publication Date
EP1883420A2 EP1883420A2 (en) 2008-02-06
EP1883420A4 true EP1883420A4 (en) 2008-08-27

Family

ID=37115868

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06750581A Withdrawn EP1883420A4 (en) 2005-04-18 2006-04-18 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease

Country Status (4)

Country Link
EP (1) EP1883420A4 (en)
AU (1) AU2006236406B2 (en)
CA (1) CA2605442A1 (en)
WO (1) WO2006113723A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206564B2 (en) 2007-07-23 2012-06-26 Bayer Healthcare Llc Biosensor calibration system
US7809512B2 (en) 2007-11-11 2010-10-05 Bayer Healthcare Llc Biosensor coding system
WO2009076263A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc An auto-calibrating test sensor and method of making the same
US8032321B2 (en) 2008-07-15 2011-10-04 Bayer Healthcare Llc Multi-layered biosensor encoding systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041152A2 (en) * 2002-05-06 2004-05-21 The Regents Of The University Of Michigan Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010006788A1 (en) * 1998-12-29 2001-07-05 Thomas E. Carey Identifying the antigenic target of autoimmune sensorineural hearing loss (aisnhl) and developement of specific tests for diagnosis and management of aisnhl

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041152A2 (en) * 2002-05-06 2004-05-21 The Regents Of The University Of Michigan Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MOSCICKI R A ET AL: "Serum antibody to innear ear proteins in patients with progressive haering loss. Correlation with disease activity and response to corticosteroid treatment", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, CHICAGO,IL, US, vol. 272, no. 8, 24 August 1994 (1994-08-24), pages 611 - 616, XP009102448, ISSN: 0098-7484 *
NAIR S T ET AL: "Identification and Characterization of Choline Transporter-Like Protein 2, an Inner Ear Glycoprotein of 68 and 72 kDa That is the Target of Antibody-Induced Hearing Loss", 18 February 2004, JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, PAGE(S) 1772 - 1779, ISSN: 0270-6474, XP008081841 *
See also references of WO2006113723A2 *
ZAVOD M B ET AL: "Frequency of cochlear enhancement on magnetic resonance imaging in patients with autoimmune sensorineural hearing loss.", August 2000, ARCHIVES OF OTOLARYNGOLOGY--HEAD & NECK SURGERY AUG 2000, VOL. 126, NR. 8, PAGE(S) 969 - 971, ISSN: 0886-4470, XP002486360 *

Also Published As

Publication number Publication date
WO2006113723A2 (en) 2006-10-26
AU2006236406A1 (en) 2006-10-26
EP1883420A2 (en) 2008-02-06
CA2605442A1 (en) 2006-10-26
WO2006113723A3 (en) 2007-06-14
AU2006236406B2 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
EP2024745A4 (en) Assays for diagnosing and evaluating treatment options for fabry disease
EP1806581A4 (en) Disease diagnosing system
IL188231A0 (en) Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
EP1721156A4 (en) Systems and methods for disease diagnosis
EP2406636A4 (en) Methods of diagnosing and predicting renal disease
IL188307A0 (en) Techniques for prediction and monitoring of clinical episodes
EP1907409A4 (en) Methods for diagnosis or prognosis of late age onset disease
EP1815872A4 (en) Composition for amyloid-associated disease diagnosis
PT1949285T (en) Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
EP2118772A4 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
IL187859A0 (en) Diagnosis and prognosis of diabetes
EP1743245A4 (en) Compactor independent fault diagnosis
EP1616035A4 (en) Caries risk test for predicting and assessing the risk of disease
GB0401730D0 (en) Diagnosis method
WO2009065132A8 (en) Predicting and diagnosing patients with autoimmune disease
ZA201001486B (en) Diagnosis,staging and monitoring of inflammatory bowel disease
GB0526330D0 (en) Engine health monitoring
EP1787116A4 (en) Methods for assessing the risk for development of cardiovascular disease
EP1844158A4 (en) Biomarker for inflammatory bowel disease
EP2260107A4 (en) Assays for diagnosing and evaluating treatment options for pompe disease
GB0521098D0 (en) Methods for diagnosing and monitoring psychotic disorders
EP1870710A4 (en) Biomarker for diagnosing heart disease and the use thereof
EP1773203A4 (en) State based birth monitoring system
EP1845848A4 (en) Method for monitoring early treatment response
EP1883420A4 (en) Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071116

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

A4 Supplementary search report drawn up and despatched

Effective date: 20080729

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/564 20060101ALI20080718BHEP

Ipc: A61K 39/00 20060101AFI20071203BHEP

17Q First examination report despatched

Effective date: 20081114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131101